by ginger | Jun 19, 2015 | citizen science, crowdsourcing, mark2cure, sulab
At long last, the wait is over! Matt Might’s talk NGLY1 story and Andrew’s talk on Mark2Cure at the Stanford Big Data in Biomedicine conference are finally online! Thanks to the efforts of our amazing Mark2Curators, the Alacrima doc set is now complete!...
by ginger | Jun 12, 2015 | citizen science, crowdsourcing, mark2cure, sulab
With Father’s day coming up and after meeting many inspirational Mark2Curators, we’ve decided to have a photo contest! The prize is one of three really lovely Mark2Cure T-shirts. Here’s how to enter: Take a selfie or a photo with a sign explaining...
by ginger | Jun 5, 2015 | citizen science, crowdsourcing, mark2cure, sulab
So far, we’ve heard from quite a few of our Mark2Curators offering a number of great suggestions, and pointing out bugs that need to be fixed. Currently, we have plans to make the green and blue more distinct (thank you all for pointing this out to us!), but...
by ginger | May 29, 2015 | citizen science, crowdsourcing, mark2cure, sulab
This week, we are happy to add a new doc set and introduce a new feature. Given that our awesome Mark2Curators have already completed about 27% of the CDG quests, the next document set (o-linked glycosylation disorders) has been loaded and is ready to go! Earlier this...
by ginger | May 21, 2015 | citizen science, crowdsourcing, mark2cure, sulab
The Campaign for NGLY1 is now live and underway! Help us get the word out! There are will be some excellent talks surrounding Mark2Cure: Campaign for NGLY1, TODAY! First of all, Matt Might (Bertrand’s dad) is giving a talk for the 3rd Big Data for Biomedicines...
by ginger | May 15, 2015 | citizen science, crowdsourcing, mark2cure, open participation science, sulab
On Tuesday (just three days ago) we invited everyone on the Mark2Cure mailing list to jump in and try the new Mark2Cure campaign. In just one day, the first quest was completed. We’ve had a bit of a rough start with the spam filter blocking the majority of the...
